Perimenopause symptoms and support
Some people with ADHD say concentration, organisation and emotional regulation worsen during perimenopause and that medication feels less reliable. Research is growing, but it does not yet provide a standard UK medication-adjustment protocol. Never change stimulant, non-stimulant or HRT doses without the relevant prescriber.
Medical disclaimer: This article provides general UK health information and is not a diagnosis or a substitute for individual medical advice. Symptoms linked online with perimenopause can also have other causes. Speak to a GP, pharmacist, dentist, optometrist or other qualified healthcare professional as appropriate. Use NHS 111 or 999 when symptoms are urgent.
What the current evidence says
A 2025 population-based Icelandic cohort compared 535 women reporting ADHD with 4,857 without ADHD. Severe perimenopausal symptoms were more common in the ADHD group, and the difference was most pronounced at ages 35 to 39. This important association does not prove an earlier biological menopause or show how medication should be changed.
A separate 2025 King’s College London exploratory study of 656 women aged 45 to 60, including 245 with diagnosed ADHD, found no significant group effect of ADHD diagnosis or medication on menopausal complaints after correction for multiple testing. ADHD symptoms and menopause complaints were correlated, but the results highlight uncertainty and possible differences in how overlapping symptoms are attributed. Good content should report both findings.
Why medication may feel different
Inattention, working-memory problems, sleep loss, anxiety, low mood, hot flushes and fatigue can all reduce day-to-day functioning. If several worsen together, it may feel as if an ADHD medicine has stopped working even when blood levels have not been measured or changed. Menstrual-cycle timing, inconsistent dosing, food, alcohol, other medicines and stress may also influence perceived benefit or side effects.
The ADHD Foundation’s UK guide explains the proposed interaction between oestrogen, dopamine and cognition, but also recognises that hormonal fluctuations and individual experiences are complicated. Mechanistic plausibility is not the same as evidence for a particular dose change.
What not to do
Do not take extra medication, split doses differently, borrow medicine, stop suddenly or combine stimulants with unregulated products based on social-media advice. ADHD medicines can affect pulse, blood pressure, sleep, appetite and anxiety, and changes need the clinician responsible for prescribing and monitoring.
Do not assume HRT will restore medication response or treat ADHD. HRT can be discussed for menopause-associated symptoms under NICE guidance, while ADHD treatment remains a separate clinical decision. Coordination may be needed between a GP, menopause clinician and ADHD prescriber because one service may not manage both prescriptions.
Track function, not just feelings
For four to eight weeks, record medication name and prescribed timing, cycle or bleeding day, sleep duration, hot flushes, anxiety or mood, appetite, caffeine, alcohol and specific functional outcomes. Examples include missed appointments, task initiation, errors at work, driving concentration or ability to complete household tasks.
Use a simple 0-to-10 score consistently rather than writing a long narrative each day. Note side effects and whether the medicine ever works as expected. This helps the prescriber distinguish a constant loss of benefit from a cycle-linked or sleep-linked pattern.
Prepare for a joined-up review
Start with the clinician who prescribes the ADHD medication, following the service’s review process. Tell your GP if you also have new menopause-associated symptoms or a changed bleeding pattern. Bring blood-pressure or pulse readings only if a professional has asked you to monitor them and you have a reliable device.
The review may cover adherence, dose timing, sleep, mood disorders, thyroid or iron status when indicated, cardiovascular monitoring and possible perimenopause assessment. If care is split between NHS and private services, ask who is responsible for each prescription and what information can be shared.
Mental-health and safety red flags
Seek urgent help if you have suicidal thoughts, feel unable to keep yourself safe, experience severe agitation, mania-like symptoms, psychosis, chest pain, fainting or severe palpitations. Call 999 in an emergency; use NHS 111, an urgent GP service or local crisis support when appropriate.
Sleep deprivation and fluctuating mood can seriously affect functioning. Do not wait for a routine medication review if you are unsafe, unable to care for yourself or experiencing a rapid and severe change.
Questions to take to the prescriber
- Could sleep, anxiety, depression, menopause symptoms or another condition be worsening my executive function?
- Does my record show a consistent change in medication benefit or side effects?
- Are my pulse, blood pressure, weight and other monitoring up to date?
- Who should assess possible perimenopause and coordinate with this service?
- What follow-up period will show whether any agreed change is helping?
The aim is an individual, monitored plan. Current evidence supports taking the concern seriously, but not a universal instruction to increase ADHD medication during perimenopause.
Frequently asked questions
Can perimenopause make ADHD symptoms worse?
Some studies and patient reports suggest an overlap, but findings are mixed and mechanisms remain under study. Sleep, mood and menopause symptoms may also worsen executive functioning.
Should stimulant doses be increased before a period?
There is no universal UK recommendation to do this. Dose changes must be made by the relevant prescriber after individual assessment and monitoring.
Will HRT make ADHD medication work again?
That is not established. HRT may be considered for menopause-associated symptoms, while ADHD medication response requires its own clinical review.
Useful next steps
UK sources and research
We prioritised current UK clinical guidance, NHS information, professional bodies and peer-reviewed research. Social-media discussions informed the questions covered, not the medical conclusions.
About this guide
Published by The Menopause Directory editorial team for UK readers. It is designed to help you recognise questions to raise with an appropriate healthcare professional, not to tell you what condition you have or which treatment to use.
Editorial review date: 18 July 2026. Review sooner if NICE, NHS or relevant professional guidance changes.
Author: The Menopause Directory
About this guide
This guide is published by The Menopause Directory editorial team to help UK readers understand menopause symptoms, support options and services. It is for general information only and should not replace advice from a GP, pharmacist or qualified menopause specialist.
Last reviewed by The Menopause Directory editorial team.